These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37081842)
41. RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer. Zhuo J; Han J; Zhao Y; Hao R; Shen C; Li H; Dai L; Sheng A; Yao H; Yang X; Liu W Sci Rep; 2023 Sep; 13(1):15252. PubMed ID: 37709911 [TBL] [Abstract][Full Text] [Related]
42. The Clinical Significance of Ye T; Wan X; Li J; Feng J; Guo J; Li G; Liu J Onco Targets Ther; 2020; 13():199-214. PubMed ID: 32021267 [TBL] [Abstract][Full Text] [Related]
43. A comprehensive analysis of the diagnostic and prognostic value associated with the Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318 [TBL] [Abstract][Full Text] [Related]
44. Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte. Chen Z; Li R; Fang M; Wang Y; Bi A; Yang L; Song T; Li Y; Li Q; Lin B; Jia Y; Fu S; Fu S; Xiong H Int J Med Sci; 2023; 20(8):1060-1078. PubMed ID: 37484811 [No Abstract] [Full Text] [Related]
45. FAM49B promotes breast cancer proliferation, metastasis, and chemoresistance by stabilizing ELAVL1 protein and regulating downstream Rab10/TLR4 pathway. Li Y; Xiong Y; Wang Z; Han J; Shi S; He J; Shen N; Wu W; Wang R; Lv W; Deng Y; Liu W Cancer Cell Int; 2021 Oct; 21(1):534. PubMed ID: 34645466 [TBL] [Abstract][Full Text] [Related]
46. Down-regulation of CCL17 in cancer-associated fibroblasts inhibits cell migration and invasion of breast cancer through ERK1/2 pathway. Li J; Yang C; Yang J; Zou L Cancer Manag Res; 2019; 11():7439-7453. PubMed ID: 31496803 [TBL] [Abstract][Full Text] [Related]
47. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer. Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y PeerJ; 2023; 11():e15654. PubMed ID: 37520246 [TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497. Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095 [TBL] [Abstract][Full Text] [Related]
49. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN. Xiao S; Zhu H; Luo J; Wu Z; Xie M Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259 [TBL] [Abstract][Full Text] [Related]
50. Increased Liu J; He Y; Li C; Zhou R; Yuan Q; Hou J; Wu G Transl Cancer Res; 2021 Sep; 10(9):4009-4019. PubMed ID: 35116699 [TBL] [Abstract][Full Text] [Related]
51. Reduced PDZRN4 promotes breast cancer progression and predicts poor prognosis. Lu YL; Yang X; Liu YK Int J Clin Exp Pathol; 2019; 12(1):142-153. PubMed ID: 31933728 [TBL] [Abstract][Full Text] [Related]
52. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
53. Transmembrane protein 92 performs a tumor-promoting function in breast carcinoma by contributing to the cell growth, invasion, migration and epithelial-mesenchymal transition. Lin MZ; Teng LL; Sun XL; Zhang LP; Chen F; Yu LJ Tissue Cell; 2020 Dec; 67():101415. PubMed ID: 32835947 [TBL] [Abstract][Full Text] [Related]
54. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer. Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115 [TBL] [Abstract][Full Text] [Related]
55. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer. Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941 [TBL] [Abstract][Full Text] [Related]
56. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer. Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979 [TBL] [Abstract][Full Text] [Related]
57. ADAMTS8 Inhibits Cell Proliferation and Invasion, and Induces Apoptosis in Breast Cancer. Zhang K; Tian R; Wang G; Zhang J; Ma H; Hu X; Xi J; Wang G Onco Targets Ther; 2020; 13():8373-8382. PubMed ID: 32904790 [TBL] [Abstract][Full Text] [Related]
58. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway. Wang G; Wu Y; Su Y; Qu N; Chen B; Zhou D; Yuan L; Yin M; Liu M; Zhou W J Transl Med; 2024 Aug; 22(1):745. PubMed ID: 39113057 [TBL] [Abstract][Full Text] [Related]
59. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth. Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252 [TBL] [Abstract][Full Text] [Related]
60. Development of lymph node metastasis-related prognostic markers in breast cancer. Pan Y; Zou Q; Yin W; Huang Z; Zhao Y; Mo Z; Li L; Yang J J Proteomics; 2024 Jan; 291():105045. PubMed ID: 37939914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]